|
Market Closed -
OTC Markets
15:14:04 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 246.15 USD | +6.21% |
|
-3.60% | -16.15% |
| 09-11 | AlphaValue/Baader Europe Sees UCB Share Drop as 'Rare Window of Affordability'; Price Target Up | MT |
| 09-10 | UCB: A rare window of affordability |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UCB | Biopharmaceuticals | +6.21% | -3.60% | -16.15% | -2.01% | +114.55% | 45.5B |
-
|
-
|
-
|
- Stock Market
- Stocks
- UCB Stock
- UCBJF Stock
- Charts UCB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
